Hai Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hai Pan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Gang Huang
2 shared publicationsIzydor Apostol
2 shared publicationsFrancis Kinderman
Analytical and Formulation Sciences, Amgen Inc., MS 30E‐1‐B, One Amgen Center Drive, Thousand Oaks, California 91320‐1799
1 shared publicationGregory C. Flynn
Process and Product Development, Amgen Inc., Thousand Oaks, CA, USA
1 shared publicationJeremy Primack
Process and Product Development, Amgen Inc., Thousand Oaks, CA, USA
1 shared publicationKen Chen
1 shared publication
Latest Publications
- 18 April 2011
- Published by Wiley in Electrophoresis
- Vol. 32 (10) , 1129-1132
A high‐throughput microchip‐based glycan screening assay for antibody cell culture samples
A high‐throughput screening assay was developed to quantify major glycan species in the crude mammalian cell culture samples for monoclonal antibodies (mAbs). This method utilizes high‐speed microchip electrophoresis separation following a fast sample preparation procedure. Using a 96‐well ultra‐filtration membrane, interfering species in the cell culture media were efficiently removed as the samples were concentrated. A commercial microchip electrophoresis instrument was used for high‐speed separation, allowing each sample to be analyzed in less than 1 min. This method is well suited for the purpose of high‐throughput antibody glycan profiling during cell culture expression, including clone selection and cell culture process optimization. The relative levels of high mannose (HM), fucosylated and galactosylated glycan species in the Fc domain can be determined for hundreds of crude cell culture samples in a few hours.
- 18 April 2011
- Published by Wiley in Electrophoresis
- Vol. 32 (10) , 1129-1132
A high‐throughput microchip‐based glycan screening assay for antibody cell culture samples
A high‐throughput screening assay was developed to quantify major glycan species in the crude mammalian cell culture samples for monoclonal antibodies (mAbs). This method utilizes high‐speed microchip electrophoresis separation following a fast sample preparation procedure. Using a 96‐well ultra‐filtration membrane, interfering species in the cell culture media were efficiently removed as the samples were concentrated. A commercial microchip electrophoresis instrument was used for high‐speed separation, allowing each sample to be analyzed in less than 1 min. This method is well suited for the purpose of high‐throughput antibody glycan profiling during cell culture expression, including clone selection and cell culture process optimization. The relative levels of high mannose (HM), fucosylated and galactosylated glycan species in the Fc domain can be determined for hundreds of crude cell culture samples in a few hours.
- 1 May 2009
- Published by Elsevier in Analytical Biochemistry
- Vol. 388 (2) , 273-278
Quantitation of soluble aggregates in recombinant monoclonal antibody cell culture by pH-gradient protein A chromatography
- 1 May 2009
- Published by Elsevier in Analytical Biochemistry
- Vol. 388 (2) , 273-278
Quantitation of soluble aggregates in recombinant monoclonal antibody cell culture by pH-gradient protein A chromatography
- Open Access
- 21 January 2009
- Published by Wiley in Protein Science
- Vol. 18 (2) , 424-433
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Susceptibility of methionine residues to oxidation is a significant issue of protein therapeutics. Methionine oxidation may limit the product's clinical efficacy or stability. We have studied kinetics of methionine oxidation in the Fc portion of the human IgG2 and its impact on the interaction with FcRn and Protein A. Our results confirm previously published observations for IgG1 that two analogous solvent‐exposed methionine residues in IgG2, Met 252 and Met 428, oxidize more readily than the other methionine residue, Met 358, which is buried inside the Fc. Met 397, which is not present in IgG1 but in IgG2, oxidizes at similar rate as Met 358. Oxidation of two labile methionines, Met 252 and Met 428, weakens the binding of the intact antibody with Protein A and FcRn, two natural protein binding partners. Both of these binding partners share the same binding site on the Fc. Additionally, our results shows that Protein A may serve as a convenient and inexpensive surrogate for FcRn binding measurements.
- 21 January 2009
- Published by Wiley in Protein Science
- Vol. 18 (2) , 424-433
Open AccessMethionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn
Susceptibility of methionine residues to oxidation is a significant issue of protein therapeutics. Methionine oxidation may limit the product's clinical efficacy or stability. We have studied kinetics of methionine oxidation in the Fc portion of the human IgG2 and its impact on the interaction with FcRn and Protein A. Our results confirm previously published observations for IgG1 that two analogous solvent‐exposed methionine residues in IgG2, Met 252 and Met 428, oxidize more readily than the other methionine residue, Met 358, which is buried inside the Fc. Met 397, which is not present in IgG1 but in IgG2, oxidizes at similar rate as Met 358. Oxidation of two labile methionines, Met 252 and Met 428, weakens the binding of the intact antibody with Protein A and FcRn, two natural protein binding partners. Both of these binding partners share the same binding site on the Fc. Additionally, our results shows that Protein A may serve as a convenient and inexpensive surrogate for FcRn binding measurements.